140 related articles for article (PubMed ID: 37236028)
1. The roles, molecular interactions, and therapeutic value of CDK16 in human cancers.
Wang X; Liu R; Li S; Xia W; Guo H; Yao W; Liang X; Lu Y; Zhang H
Biomed Pharmacother; 2023 Aug; 164():114929. PubMed ID: 37236028
[TBL] [Abstract][Full Text] [Related]
2. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16.
Dixon-Clarke SE; Shehata SN; Krojer T; Sharpe TD; von Delft F; Sakamoto K; Bullock AN
Biochem J; 2017 Feb; 474(5):699-713. PubMed ID: 28057719
[TBL] [Abstract][Full Text] [Related]
3. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.
Li X; Li J; Xu L; Wei W; Cheng A; Zhang L; Zhang M; Wu G; Cai C
J Exp Clin Cancer Res; 2022 Apr; 41(1):149. PubMed ID: 35449080
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis.
Mikolcevic P; Sigl R; Rauch V; Hess MW; Pfaller K; Barisic M; Pelliniemi LJ; Boesl M; Geley S
Mol Cell Biol; 2012 Feb; 32(4):868-79. PubMed ID: 22184064
[TBL] [Abstract][Full Text] [Related]
5. PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.
Yanagi T; Hata H; Mizuno E; Kitamura S; Imafuku K; Nakazato S; Wang L; Nishihara H; Tanaka S; Shimizu H
J Dermatol Sci; 2017 May; 86(2):149-157. PubMed ID: 28274513
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel PCTAIRE-1/CDK16 substrates using a chemical genetic screen.
Shehata SN; Deak M; Collodet C; Spiegl SF; Geley S; Sumpton D; Sakamoto K
Cell Signal; 2019 Jul; 59():53-61. PubMed ID: 30880224
[TBL] [Abstract][Full Text] [Related]
7. Cyclin Y phosphorylation- and 14-3-3-binding-dependent activation of PCTAIRE-1/CDK16.
Shehata SN; Deak M; Morrice NA; Ohta E; Hunter RW; Kalscheuer VM; Sakamoto K
Biochem J; 2015 Aug; 469(3):409-20. PubMed ID: 26205494
[TBL] [Abstract][Full Text] [Related]
8. Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.
Mikolcevic P; Rainer J; Geley S
Cell Cycle; 2012 Oct; 11(20):3758-68. PubMed ID: 22895054
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-Amino-1
Amrhein JA; Berger LM; Tjaden A; Krämer A; Elson L; Tolvanen T; Martinez-Molina D; Kaiser A; Schubert-Zsilavecz M; Müller S; Knapp S; Hanke T
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499165
[TBL] [Abstract][Full Text] [Related]
10. CDK16 overexpressed in non-small cell lung cancer and regulates cancer cell growth and apoptosis via a p27-dependent mechanism.
Wang H; Liu H; Min S; Shen Y; Li W; Chen Y; Wang X
Biomed Pharmacother; 2018 Jul; 103():399-405. PubMed ID: 29674275
[TBL] [Abstract][Full Text] [Related]
11. Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex.
Hernández-Ortega S; Sánchez-Botet A; Quandt E; Masip N; Gasa L; Verde G; Jiménez J; Levin RS; Rutaganira FU; Burlingame AL; Wolfgeher D; Ribeiro MPC; Kron SJ; Shokat KM; Clotet J
Exp Mol Med; 2019 Apr; 51(4):1-17. PubMed ID: 30992425
[TBL] [Abstract][Full Text] [Related]
12. CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse.
Zi Z; Zhang Z; Li Q; An W; Zeng L; Gao D; Yang Y; Zhu X; Zeng R; Shum WW; Wu J
PLoS Genet; 2015 Aug; 11(8):e1005485. PubMed ID: 26305884
[TBL] [Abstract][Full Text] [Related]
13. Pctaire1/Cdk16 promotes skeletal myogenesis by inducing myoblast migration and fusion.
Shimizu K; Uematsu A; Imai Y; Sawasaki T
FEBS Lett; 2014 Aug; 588(17):3030-7. PubMed ID: 24931367
[TBL] [Abstract][Full Text] [Related]
14. CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers.
Qi J; Wu G; He M; Xu Y; Yang Z; Ding L; Wang Y; Zhang Z
Aging (Albany NY); 2024 Jan; 16(2):1879-1896. PubMed ID: 38261737
[TBL] [Abstract][Full Text] [Related]
15. CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.
Xie J; Li Y; Jiang K; Hu K; Zhang S; Dong X; Dai X; Liu L; Zhang T; Yang K; Huang K; Chen J; Shi S; Zhang Y; Wu G; Xu S
Theranostics; 2018; 8(3):650-662. PubMed ID: 29344296
[No Abstract] [Full Text] [Related]
16. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
Zhao JA; Nie W; Dong L; Liu W; Wei W
J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
[TBL] [Abstract][Full Text] [Related]
17. Baicalin Blocks Colon Cancer Cell Cycle and Inhibits Cell Proliferation through miR-139-3p Upregulation by Targeting CDK16.
Cai R; Zhou YP; Li YH; Zhang JJ; Hu ZW
Am J Chin Med; 2023; 51(1):189-203. PubMed ID: 36599649
[TBL] [Abstract][Full Text] [Related]
18. Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth.
Yanagi T; Tachikawa K; Wilkie-Grantham R; Hishiki A; Nagai K; Toyonaga E; Chivukula P; Matsuzawa S
Mol Ther Nucleic Acids; 2016 Jun; 5(6):e327. PubMed ID: 27351680
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.
Wang Y; Qin X; Guo T; Liu P; Wu P; Liu Z
J Exp Clin Cancer Res; 2017 Jul; 36(1):97. PubMed ID: 28716136
[TBL] [Abstract][Full Text] [Related]
20. The CCNY (cyclin Y)-CDK16 kinase complex: a new regulator of autophagy downstream of AMPK.
Vervoorts J; Neumann D; Lüscher B
Autophagy; 2020 Sep; 16(9):1724-1726. PubMed ID: 32723157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
